Similar articles for PMID: 28718815

Year	Number of Results
2012	1
2014	1
2015	3
2016	3
2017	10
2018	14
2019	6
2020	16
2021	17
2022	22
2023	21
2024	0

1

Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy.

Sridhar P, Petrocca F. Sridhar P, et al. Cancers (Basel). 2017 Jul 18;9(7):92. doi: 10.3390/cancers9070092. Cancers (Basel). 2017. PMID: 28718815 Free PMC article. Review.

2

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery.

Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP. Katz SC, et al. Cancer Gene Ther. 2016 May;23(5):142-8. doi: 10.1038/cgt.2016.14. Epub 2016 Apr 15. Cancer Gene Ther. 2016. PMID: 27080226 Free PMC article.

3

Locoregional delivery of CAR-T cells in the clinic.

Sagnella SM, White AL, Yeo D, Saxena P, van Zandwijk N, Rasko JEJ. Sagnella SM, et al. Pharmacol Res. 2022 Aug;182:106329. doi: 10.1016/j.phrs.2022.106329. Epub 2022 Jun 27. Pharmacol Res. 2022. PMID: 35772645 Review.

4

Chimeric antigen receptor-engineered T-cell therapy for liver cancer.

Chen Y, E CY, Gong ZW, Liu S, Wang ZX, Yang YS, Zhang XW. Chen Y, et al. Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):301-309. doi: 10.1016/j.hbpd.2018.05.005. Epub 2018 May 24. Hepatobiliary Pancreat Dis Int. 2018. PMID: 29861325 Review.

5

Effective Targeting of TAG72⁺ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells.

Murad JP, Kozlowska AK, Lee HJ, Ramamurthy M, Chang WC, Yazaki P, Colcher D, Shively J, Cristea M, Forman SJ, Priceman SJ. Murad JP, et al. Front Immunol. 2018 Nov 19;9:2268. doi: 10.3389/fimmu.2018.02268. eCollection 2018. Front Immunol. 2018. PMID: 30510550 Free PMC article.

6

Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2⁺ Breast Cancer Metastasis to the Brain.

Priceman SJ, Tilakawardane D, Jeang B, Aguilar B, Murad JP, Park AK, Chang WC, Ostberg JR, Neman J, Jandial R, Portnow J, Forman SJ, Brown CE. Priceman SJ, et al. Clin Cancer Res. 2018 Jan 1;24(1):95-105. doi: 10.1158/1078-0432.CCR-17-2041. Epub 2017 Oct 23. Clin Cancer Res. 2018. PMID: 29061641 Free PMC article.

7

Update for Advance CAR-T Therapy in Solid Tumors, Clinical Application in Peritoneal Carcinomatosis From Colorectal Cancer and Future Prospects.

Qian S, Villarejo-Campos P, Guijo I, Hernández-Villafranca S, García-Olmo D, González-Soares S, Guadalajara H, Jiménez-Galanes S, Qian C. Qian S, et al. Front Immunol. 2022 Mar 25;13:841425. doi: 10.3389/fimmu.2022.841425. eCollection 2022. Front Immunol. 2022. PMID: 35401510 Free PMC article. Review.

8

Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma.

Zhou S, Sun H, Choi SI, Yin J. Zhou S, et al. Front Biosci (Landmark Ed). 2023 Sep 15;28(9):206. doi: 10.31083/j.fbl2809206. Front Biosci (Landmark Ed). 2023. PMID: 37796692 Free article. Review.

9

Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells.

Nellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DW. Nellan A, et al. J Immunother Cancer. 2018 Apr 30;6(1):30. doi: 10.1186/s40425-018-0340-z. J Immunother Cancer. 2018. PMID: 29712574 Free PMC article.

10

Mesothelin-targeted CAR-T cell therapy for solid tumors.

Klampatsa A, Dimou V, Albelda SM. Klampatsa A, et al. Expert Opin Biol Ther. 2021 Apr;21(4):473-486. doi: 10.1080/14712598.2021.1843628. Epub 2020 Nov 12. Expert Opin Biol Ther. 2021. PMID: 33176519 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year